BofA analyst Farrell Granath raised the firm's price target on Medical Properties Trust to $4.50 from $4 and keeps an Underperform rating on the shares. While stock performance did not reflect it, Q3 earnings season was "strong" for U.S. REITs as 69% of REITs beat the Street, the analyst tells investors in a note on the group.
